Skip to main content
. 2023 Mar 22;130(9):1558–1572. doi: 10.1017/S0007114523000739

Table 2.

Se biomarker concentrations at delivery and in infant venous cord blood

(numbers and percentages; mean values and standard deviations)

Biomarkers* Maternal delivery specimens Infant venous cord specimens
WBSe Serum Se SEPP1 WBSe SEPP1
n % n % n % n % n %
n* 467 517 677 448 562
Se biomarker concentration (µg/l)
  Mean 133·5 68·6 2144·0 159·2 1535·0
  sd 17·8 12·8 712·0 22·0 522·8
Minimum, maximum (µg/l) 80·5, 190·6 4·5, 110·3 524·8, 4968·4 88·1, 233·4 117·2, 3800·6
 < Threshold* 12 2·6 431 83·4 1 0·2
 Deficient 1 0·2
C-reactive protein (CRP) maternal delivery plasma, n 437 509 672 417 535
CRP maternal delivery plasma (mg/l)
  Median 9 8 8 17 8
  IQR 18 16 18 24 15
CRP venous cord plasma, n 272 322 427 348 450
CRP venous cord plasma (mg/l)
  Median 1 1 1 0·8 1
  IQR 1 0 0 0·4 0
CRP venous cord plasma (detectable) 202 74 254 79 342 80 263 76 356 79

SEPP1, selenoprotein P; IQR, inter-quartile range.

*

WBSe above threshold defined as concentrations ≥ 100 µg/land serum Se ≥ 80 µg/l.

Deficiency defined as serum Se < 30 µg/l.